These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 171513)

  • 1. Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J; Messerli FH; Honda M; Tolis G; Seth K; Parvin-Pande R; Kubo S; Grose J; Ledoux F; Lebel M
    J Steroid Biochem; 1975 May; 6(5):767-78. PubMed ID: 171513
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal regulation of aldosterone in hypertension.
    Luetscher JA; Ganguly A; Melada GA; Dowdy AJ
    Adv Intern Med; 1975; 20():183-96. PubMed ID: 163569
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of posture on the plasma concentrations of aldosterone in hypertension and primary hyperaldosteronism.
    Biglieri EG
    Nephron; 1979; 23(2-3):112-5. PubMed ID: 220544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of 18-hydroxy-11-deoxycorticosterone in essential hypertension.
    Honda M; Den K; Kanbegawa A; Ueda Y; Tsuchiya M; Izumi Y; Oguri K; Shiratsuchi T; Hatano M
    Endocrinol Jpn; 1978 Jun; 25(3):237-43. PubMed ID: 211025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiological regulation and clinical significance of 18-hydroxy-11-deoxycorticosterone].
    Li G; Kuang AK; Ding T
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):94-7, 126. PubMed ID: 2985345
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of 18-hydroxydeoxycorticosterone in the rat.
    Tan SY; Mulrow PJ
    Endocrinology; 1978 Apr; 102(4):1113-7. PubMed ID: 217614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension of childhood with suppressed renin.
    New MI; Levine LS
    Endocr Rev; 1980; 1(4):421-30. PubMed ID: 6265200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma aldosterone levels in primary aldosteronism. II. Aldosterone and ACTH].
    Fukuchi S; Takenouchi T; Nakajima K; Sasaki C
    Nihon Naibunpi Gakkai Zasshi; 1973 Jul; 49(7):981-7. PubMed ID: 4353327
    [No Abstract]   [Full Text] [Related]  

  • 10. Mineralocorticoid properties of potential metabolites of 18-hydroxydeoxycorticosterone and 18-hydroxyprogesterone.
    Weet JF; Lenz GR
    J Med Chem; 1985 Feb; 28(2):233-9. PubMed ID: 3155800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal steroidogenesis in "low renin" or hyporeninemic hypertension.
    Melby JC; Dale SL
    J Steroid Biochem; 1975 May; 6(5):761-6. PubMed ID: 1186255
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of 18-hydroxy-11-deoxycorticosterone in plasma.
    Dale SL; Komanicky P; Pratt JH; Melby JC
    J Clin Endocrinol Metab; 1976 Oct; 43(4):803-9. PubMed ID: 185232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
    Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
    J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism].
    Shkhvatsabaia IK; Pershakova LP; Ustinova SE; Chikhladze NM; Uchitel' IA
    Kardiologiia; 1985 Jan; 25(1):16-22. PubMed ID: 2984449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influences of ACTH, dietary sodium, upright posture and angiotensin II on plasma 18-hydroxy-11-deoxycorticosterone levels in normal subjects.
    Tuck ML; Chandler DW; Mayes DM
    J Clin Endocrinol Metab; 1977 Nov; 45(5):893-902. PubMed ID: 200632
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of bilateral adrenocortical nodular hyperplasia with hypertension, hypokalemia, and elevated serum 18-OH-DOC levels].
    Nakanishi T; Fukumoto Y; Kuroda K; Tokunaga K
    Nihon Naika Gakkai Zasshi; 1988 May; 77(5):680-4. PubMed ID: 2851027
    [No Abstract]   [Full Text] [Related]  

  • 18. Arterial levels and mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone in the rat.
    Nicholls MG; Brown WC; Hay GD; Mason PA; Fraser R
    J Steroid Biochem; 1979 Jan; 10(1):67-70. PubMed ID: 513718
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)].
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
    New MI; Peterson RE; Saenger P; Levine LS
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.